Subscribe To
Angion biomedica pulls the plug on another kidney disease trial - read why
Angion Biomedica Corp (NASDAQ: ANGN) has discontinued the JUNIPER Phase 2 trial of ANG-3070, an oral tyrosine ...
June 30, 2022, 6:11 am
Nuvalent to present at the 2022 jefferies healthcare conference
CAMBRIDGE, Mass. , June 2, 2022 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisel...
June 2, 2022, 6:38 am
Brp group, inc.'s (brp) ceo trevor baldwin on q1 2022 results - earnings call transcript
BRP Group, Inc. (NASDAQ:BRP ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Bonnie Bishop - Executive Director, Invest...
May 14, 2022, 11:25 pm
Lemonade, inc. (lmnd) management on q1 2022 results - earnings call transcript
Lemonade, Inc. (NYSE:LMND ) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Yael Wissner-Levy - Head, Content and Commun...
May 10, 2022, 1:50 pm
kinaxis inc. (kxscf) ceo john sicard on q1 2022 results - earnings call transcript
kinaxis Inc. (OTCPK:KXSCF) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants...
May 6, 2022, 1:22 pm
Renaissancere holdings ltd. (rnr) ceo kevin o'donnell on q1 2022 results - earnings call transcript
RenaissanceRe Holdings Ltd. (NYSE:RNR ) Q1 2022 Earnings Conference Call May 4, 2022 11:00 AM ET Company Participants Kevin O'Donnell – President & ...
May 4, 2022, 3:28 pm
Lantheus holdings, inc. (lnth) ceo mary anne heino on q1 2022 results - earnings call transcript
Lantheus Holdings, Inc. (NASDAQ:LNTH ) Q1 2022 Results Earnings Conference Call April 29, 2022 8:00 AM ET Company Participants Mark ...
April 29, 2022, 2:43 pm
Arch capital group ltd (acgl) ceo marc grandisson on q1 2022 results - earnings call transcript
Arch Capital Group Ltd (NASDAQ:ACGL ) Q1 2022 Earnings Conference Call April 28, 2022 11:00 AM ET Company Participants Marc Grandisson - Chief Executi...
April 28, 2022, 10:39 pm
Willis towers watson public limited company (wtw) ceo carl hess on q1 2022 results - earnings call transcript
Willis Towers Watson Public Limited Company (NASDAQ:WTW ) Q1 2022 Results Conference Call April 28, 2022 7:00 AM ET Company Participants Carl Hess - C...
April 28, 2022, 4:43 pm
Axis capital holdings limited (axs) ceo albert benchimol on q1 2022 results - earnings call transcript
AXIS Capital Holdings Limited (NYSE:AXS ) Q1 2022 Earnings Conference Call April 28, 2022 9:30 AM ET Company Participants Matt Rohrmann - Head of IR A...
April 28, 2022, 3:49 pm
Hawaiian holdings' (ha) ceo peter ingram on q1 2022 results - earnings call transcript
Hawaiian Holdings, Inc. (NASDAQ:HA ) Q1 2022 Earnings Conference Call April 26, 2022 4:30 PM ET Company Participants Ashlee Kishimoto – Managing Dir...
April 26, 2022, 10:10 pm
Brown & brown, inc. (bro) ceo powell brown on q1 2022 results - earnings call transcript
Brown & Brown, Inc. (NYSE:BRO ) Q1 2022 Earnings Conference Call April 26, 2022 8:00 AM ET CompanyParticipants Powell Brown - President & Chief Execut...
April 26, 2022, 3:19 pm
W. r. berkley corporation's (wrb) ceo rob berkley on q1 2022 results - earnings call transcript
W. R. Berkley Corporation (NYSE:WRB ) Q1 2022 Earnings Conference Call April 25, 2022 5:00 PM ET Company Participants Rob Berkley - President and CEO ...
April 26, 2022, 12:00 am
Matson: just check 2022 guidance and capital expenditures
Matson offers ocean transportation and logistics services. The company primarily operates in Hawaii, Alaska, and Guam, but also offers services in O...
April 14, 2022, 10:20 am
Repare therapeutics to present new clinical and preclinical data at the 2022 aacr annual meeting
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage pr...
April 8, 2022, 1:00 pm
Marinus (mrns) gets fda nod for ztalmy in rare genetic disorder
The FDA approves Marinus' (MRNS) Ztalmy (ganaxolone) to treat seizures associated with cyclin-dependent kina...
March 21, 2022, 11:17 am
Nuvalent to present new preclinical data on ros1-selective inhibitor nvl-520 and alk-selective inhibitor nvl-655 at aacr annual meeting 2022
CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Nuvalent, Inc., (Nasdaq: NUVL) a biotechnology company creating precisely targeted therapies for clin...
March 8, 2022, 5:38 pm
Jazz pharmaceuticals to present pan-raf inhibitor pre-clinical data at american association for cancer research (aacr) 2022 annual meeting
DUBLIN, March 8, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that pre-clinical data on JZP815, an investigational, ne...
March 8, 2022, 4:35 pm
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios Pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemia in adults with pyruvate ...
February 18, 2022, 5:41 am
Fda approves agios' mitapivat as first disease-modifying therapy for genetic blood disorder
The FDA approved Agios Pharmaceuticals Inc's (NASDAQ: AGIO) Pyrukynd (mitapivat) for hemolytic anemia in adults with pyruvate ...
February 18, 2022, 5:41 am